GlassScriptPhysician profile
Diana M Harper
NPI 1639161219
$4,952.50
in general payments reported to CMS, 2019-2025
15 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,071 · 2022: $716 · 2023: $1,588 · 2024: $1,219 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,165.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,562.50 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $625.80 | 2021-2022 | |
| Abbott Laboratories | $523.21 | 2021-2025 | Cardiomems, Pressurewire, Xience Skypoint |
| Janssen Pharmaceuticals, INC | $312.86 | 2021-2022 | |
| Stryker Corporation | $309.21 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $207.64 | 2021-2025 | Linq II |
| Astellas Pharma US INC | $125.14 | 2021 | |
| Atricure, INC. | $84.73 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $54.45 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $53.26 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.41 | 2021 | |
| Amarin Pharma, INC. | $17.17 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.73 | 2022 | |
| Cardiva Medical, INC. | $15.64 | 2022 | |
| Biosense Webster, INC. | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.